Promethium Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.81M Buy
18,345
+667
+4% +$176K 2.36% 10
2026
Q2
$3.9M Buy
17,678
+197
+1% +$54.5K 1.87% 13
2026
Q1
$5.16M Buy
17,481
+48
+0.3% +$14.3K 2.67% 8
2025
Q4
$4.76M Buy
17,433
+1,305
+8% +$355K 2.57% 7
2025
Q3
$4.36M Buy
16,128
+619
+4% +$168K 2.5% 8
2025
Q2
$4.27M Buy
15,509
+534
+4% +$145K 2.6% 4
2025
Q1
$3.97M Buy
14,975
+2,726
+22% +$672K 2.54% 6
2024
Q4
$2.92M Buy
12,249
+456
+4% +$105K 2% 13
2024
Q3
$2.6M Buy
+11,793
New +$2.44M 1.84% 12

Other funds holding CME

Promethium Advisors's CME Position: Q3 2026 in Review

Promethium Advisors increased its CME Group (CME) stake by 3.8% in Q3 2026, buying an estimated $176K and bringing the position to 18,345 shares worth $4.81M. The position accounts for 2.36% of the portfolio, ranked #10.

Promethium Advisors first reported a position in CME in Q3 2024 and has held it in 9 quarters since. The position peaked at $5.16M in Q1 2026. 635 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Promethium Advisors held 18,345 shares of CME Group worth $4.81M as of Q3 2026.
  • Promethium Advisors bought 667 CME Group shares in Q3 2026, an estimated $176K.
  • CME Group made up 2.36% of Promethium Advisors's portfolio in Q3 2026, its #10 holding.
  • Promethium Advisors first reported a position in CME Group in Q3 2024 and has held it in 9 quarters since.
  • Promethium Advisors's CME Group position peaked at $5.16M in Q1 2026.
  • 635 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Promethium Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.